Global Market Research Report on Vitreous Tamponades Market 2016 is a professional and in-depth complete study on the current state of the Vitreous Tamponades worldwide.

Deerfield Beach, FL -- (SBWire) -- 03/16/2017 --The global vitreous tamponades market is segmented on the basis of type and geography. On the basis of type, the market is segmented into; Gaseous Tamponades such as Sulphur Hexafluoride (SF6), Hexafluoroethane (C2F6) and Octafluoropropane (C3F8); Liquid Tamponades such as Silicone Oil, Perfluorocarbons and Other accessories. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA

Mergers and acquisitions are some of the key strategies adopted by leading industry players. For instance, in the year 2011, Novartis acquired Alcon incorporated, a global leader in eye care. The companies profiled in the report include, Alcon, Inc., AL.CHI.MI.A. Srl, Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Carl Zeiss Meditec AG, CROMA-PHARMA GmbH, Fluoron GmbH, and D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.

Get Free Sample Report Of Vitreous Tamponades Market @ http://www.marketresearchstore.com/report/world-vitreous-tamponades-market-opportunities-and-forecasts-71005#RequestSample

Vitreous Tamponades are postoperative tools used in retinal detachment vitrectomy procedures. Retinal detachment is very serious medical complication and if not treated on time, can lead to permanent loss of vision. In the United States about 6% of population is estimated to suffer from retinal breaks, with annual incidences of 1 in 10,000. Vitrectomy is a surgical technique used in the correction of retinal detachment, which involves the removal of small amounts of vitreous gel from the human eye. At the end of vitrectomy, tamponades are injected into the eye to hold the retina in place and help in healing process. There is unmet market need for safe and technologically superior devices. The current viterectomy procedures are complicated and associated with adverse events such as cataract, glaucoma and recurrence of retinal detachment; making viterectomy a less invasive and a considerably successful procedure, would be a key challenge for market players. The key factors driving the vitreous tamponades market are; rising incidences of ophthalmic diseases, higher prevalence of diabetes and a global rise in the count of geriatric population, as old age and diabetes patients are at a higher risk of developing retinal diseases. However, the high cost of treatment, lack of expertise, a stringent regulatory requirement and an ambiguous reimbursement scenario are likely to restrict the market growth.

Do Inquiry To Buy Report Of Vitreous Tamponades Market @ http://www.marketresearchstore.com/report/world-vitreous-tamponades-market-opportunities-and-forecasts-71005#InquiryForBuying

KEY MARKET SEGMENT:

The global Vitreous Tamponades market is segmented below:

Global Vitreous Tamponades Market – By Type

Gaseous Tamponades
Sulphur Hexafluoride (SF6)
Hexafluoroethane (C2F6)
Octafluoropropane (C3F8)
Liquid Tamponades
Silicone Oil
Perfluorocarbons
Other accessories

Global Vitreous Tamponades Market – By Geography

North America
Europe
Asia-Pacific
LAME

Contact Us:
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/